
Insilico Medicine
Chief Scientific Officer, Executive Director & Co-CEO
via Insilico Medicine
Founder · Executive · Researcher

Founder, Chair and CEO at Insilico Medicine
Zhavoronkov helped popularize the use of deep learning and generative models in aging research and drug discovery. At Insilico, he pushed AI-designed targets and molecules toward clinical testing, including fibrosis programs, and promoted Pharma.AI as an end-to-end discovery platform. He has also written on longevity economics and authored The Ageless Generation.
See something inaccurate or outdated?
Insilico MedicineWork and education history is primarily focused on AI-relevant roles and may not be comprehensive.
Last editorial review: August 18, 2026